TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 LIST OF ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.4 FORECASTING TECHNIQUES
3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.5.1 BOTTOM-UP APPROACH
3.5.2 TOP-DOWN APPROACH
3.6 DATA TRIANGULATION
3.7 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 RISING PREVALENCE OF HEART DISEASES
4.2.2 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
4.3 RESTRAINTS
4.3.1 RISK OF INFECTION
4.3.2 COMPLICATIONS DURING CARDIAC CATHETERIZATION
4.4 OPPORTUNITIES
4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON KEY PLAYERS
5.3.3 IMPACT ON DEMAND AND SUPPLY
5.4 INSIGHTS: TECHNOLOGICAL ADVANCEMENT FOR PERCUTANEOUS CORONARY INTERVENTION PRODUCTS
6 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.1.1 CORONARY STENTS
6.1.2 BALLON CATHETERS
6.1.3 CORONARY GUIDEWIRES
6.1.4 GUIDING CATHETERS
6.1.5 GUIDING SHEATHS
6.1.6 DIAGNOSTIC CATHETERS
6.1.7 CROSSING CATHETERS
6.1.8 INFLATION DEVICE
6.1.9 GUIDANCE SYSTEM
6.1.10 PERIPHERAL THROMBECTOMY SYSTEM
6.1.11 EMBOLIC PROTECTION SYSTEM
6.1.12 ACCESSORIES
7 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS
7.1 OVERVIEW
7.1.1 RADIAL
7.1.2 FEMORAL
8 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER
8.1 OVERVIEW
8.1.1 HOSPITALS & CLINICS
8.1.2 AMBULATORY SURGICAL CENTERS
8.1.3 OTHERS
9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 SWITZERLAND
9.3.7 NETHERLAND
9.3.8 BELGIUM
9.3.9 POLAND
9.3.10 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 SINGAPORE
9.4.7 THAILAND
9.4.8 VIETNAM
9.4.9 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 AFRICA
9.5.2 LATIN AMERICA
9.5.3 MIDDLE EAST
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MARKET SHARE ANALYSIS MAJOR PLAYER
10.3.1 BOSTON SCIENTIFIC CORPORATION
10.3.2 ABBOTT
10.3.3 MEDTRONIC
10.3.4 TERUMO CORPORATION
10.3.5 MICROPORT SCIENTIFIC CORPORATION
10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
10.5 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
10.6 KEY DEVELOPMENT ANALYSIS
10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.7.1 PRODUCT LAUNCH / PRODUCT APPROVAL
10.7.2 AGREEMENT
10.8 MAJOR PLAYERS FINANCIAL
10.8.1 SALES (USD MILLION), 2022
10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022
11 COMPANY PROFILES
11.1 BOSTON SCIENTIFIC CORPORATION
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 ABBOTT
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 MEDTRONIC
11.3.1 COMPANY OVERVIEWS
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 COOK
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 MERIT MEDICAL SYSTEM
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 TERUMO CORPORATION
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY DEVELOPMENTS
11.6.6 KEY STRATEGIES
11.7 APT MEDICAL INC
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 BECTON, DICKINSON, AND COMPANY
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 B. BRAUN SE
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 CARDINAL HEALTH
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
11.11 MERIL LIFE SCIENCES PVT. LTD
11.11.1 COMPANY OVERVIEWS
11.11.2 FINANCIAL OVERVIEW
11.11.3 PRODUCTS OFFERED
11.11.4 KEY DEVELOPMENTS
11.11.5 KEY STRATEGIES
11.12 PLS MINIMALLY INVASIVE INTERVENTIONAL MEDICAL CO., LTD
11.12.1 COMPANY OVERVIEW
11.12.2 FINANCIAL OVERVIEW
11.12.3 PRODUCTS OFFERED
11.12.4 KEY DEVELOPMENTS
11.12.5 KEY STRATEGIES
11.13 MICROPORT SCIENTIFIC CORPORATION
11.13.1 COMPANY OVERVIEW
11.13.2 FINANCIAL OVERVIEW
11.13.3 PRODUCTS OFFERED
11.13.4 KEY DEVELOPMENTS
11.13.5 KEY STRATEGIES
11.14 LEPU MEDICAL TECHNOLOGY CO., LTD
11.14.1 COMPANY OVERVIEW
11.14.2 FINANCIAL OVERVIEW
11.14.3 PRODUCTS OFFERED
11.14.4 KEY DEVELOPMENTS
11.14.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 3 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CORONARY STENTS, BY REGION, 2019–2032 (USD MILLION)
TABLE 4 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 5 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 6 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CORONARY GUIDEWIRES, BY REGION, 2019–2032 (USD MILLION)
TABLE 7 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDING CATHETERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 8 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDING SHEATHS, BY REGION, 2019–2032 (USD MILLION)
TABLE 9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR DIAGNOSTICS CATHETERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 10 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CROSSING CATHETERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 11 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR INFLATION DEVICE, BY REGION, 2019–2032 (USD MILLION)
TABLE 12 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDANCE SYSTEM, BY REGION, 2019–2032 (USD MILLION)
TABLE 13 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR PERIPHERAL THROMBECTOMY SYSTEM, BY REGION, 2019–2032 (USD MILLION)
TABLE 14 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR EMBOLIC PROTECTION SYSTEM, BY REGION, 2019–2032 (USD MILLION)
TABLE 15 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR ACCESSORIES, BY REGION, 2019–2032 (USD MILLION)
TABLE 16 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 17 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR RADIAL, BY REGION, 2019–2032 (USD MILLION)
TABLE 18 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR FEMORAL, BY REGION, 2019–2032 (USD MILLION)
TABLE 19 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 20 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019–2032 (USD MILLION)
TABLE 21 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 22 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 23 GLOBAL: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 24 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 25 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 26 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 27 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 28 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 29 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 30 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 31 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 32 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 33 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 34 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 35 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 36 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 37 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 38 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 39 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 40 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 41 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 42 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 43 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 44 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 45 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 46 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 47 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 48 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 49 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 50 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 51 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 52 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 53 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 54 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 55 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 56 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 57 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 58 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 59 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 60 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 61 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 62 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 63 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 64 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 65 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 66 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)
TABLE 67 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 68 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)
TABLE 69 NETHERLAN
